Skip to content

Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03090386
Enrollment
30
Registered
2017-03-24
Start date
2017-02-25
Completion date
2020-11-15
Last updated
2020-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor

Brief summary

This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.

Interventions

OTHERCognitive Surveys

Complete the Cognitive Communication Survey, standardized cognitive and language assessments, and the Follow-up Cognitive Communication Survey after treatment

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years

Inclusion criteria

* be between18 to 89 years old; * have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery) * have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study; * be native speakers of American English; * have obtained a minimum of a high school education; * self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; and * must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool.

Exclusion criteria

* are younger than 18 years old or older than 89 years old; * have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery) * have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment; * are not native speakers of American English; * have not obtained a minimum of a high school education; * do not self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; or * do not demonstrate the capacity to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Cognitive Communication Survey1 day at time of consentSurvey is completed at time of consent

Secondary

MeasureTime frameDescription
Cognitive-linguistic Standardized Testingwithin 3 months of cognitive communication surveyStandardized testing will be completed
Follow-up Surveywithin 6 months after completion of standardized testingSurvey will be completed

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026